DE69204718D1 - CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit. - Google Patents

CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit.

Info

Publication number
DE69204718D1
DE69204718D1 DE69204718T DE69204718T DE69204718D1 DE 69204718 D1 DE69204718 D1 DE 69204718D1 DE 69204718 T DE69204718 T DE 69204718T DE 69204718 T DE69204718 T DE 69204718T DE 69204718 D1 DE69204718 D1 DE 69204718D1
Authority
DE
Germany
Prior art keywords
amniotic fluid
human amniotic
immunoreactive antigen
immunoreactive
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69204718T
Other languages
English (en)
Other versions
DE69204718T2 (de
Inventor
Thomas Hyatt Duffy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Ciba Corning Diagnosys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Corning Diagnosys Corp filed Critical Ciba Corning Diagnosys Corp
Publication of DE69204718D1 publication Critical patent/DE69204718D1/de
Application granted granted Critical
Publication of DE69204718T2 publication Critical patent/DE69204718T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69204718T 1991-04-12 1992-04-09 CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit. Expired - Fee Related DE69204718T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68530191A 1991-04-12 1991-04-12

Publications (2)

Publication Number Publication Date
DE69204718D1 true DE69204718D1 (de) 1995-10-19
DE69204718T2 DE69204718T2 (de) 1996-04-18

Family

ID=24751592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69204718T Expired - Fee Related DE69204718T2 (de) 1991-04-12 1992-04-09 CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit.

Country Status (7)

Country Link
US (1) US5324822A (de)
EP (1) EP0508776B1 (de)
JP (1) JP3385572B2 (de)
AU (1) AU657102B2 (de)
CA (1) CA2055695C (de)
DE (1) DE69204718T2 (de)
HK (1) HK1000027A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5790761A (en) * 1992-12-11 1998-08-04 Heseltine; Gary L. Method and apparatus for the diagnosis of colorectal cancer
WO2012089814A1 (en) 2010-12-30 2012-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Antigen binding formats for use in therapeutic treatments or diagnostic assays
US20140235492A1 (en) 2011-09-20 2014-08-21 Institut National De La Sante Et De La Recherche Medicate (Inserm) Methods for preparing single domain antibody microarrays
WO2013174998A1 (en) 2012-05-25 2013-11-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for selecting binders by phage display and masked selection
EP2733153A1 (de) 2012-11-15 2014-05-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren zur Herstellung von Immunkonjugaten und Verwendungen davon
EP2818867A1 (de) 2013-06-27 2014-12-31 INSERM (Institut National de la Santé et de la Recherche Médicale) An mindestens ein Nucleinsäuremolekül konjugierte Antikörper und deren Verwendung in Multiplex-Immunnachweis-Assays
US20160176943A1 (en) 2013-07-05 2016-06-23 Inserm (Insititut National De La Sante Et De La Recherche Medicale) Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis
US20180327499A1 (en) 2015-11-13 2018-11-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti- nkg2d single domain antibodies and uses thereof
WO2022034523A1 (en) 2020-08-13 2022-02-17 Immunitybio, Inc. Phagocytosis-inducing compounds and methods of use
WO2022101463A1 (en) 2020-11-16 2022-05-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of the last c-terminal residues m31/41 of zikv m ectodomain for triggering apoptotic cell death
WO2023217904A1 (en) 2022-05-10 2023-11-16 Institut National de la Santé et de la Recherche Médicale Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
WO2024018003A1 (en) 2022-07-21 2024-01-25 Institut National de la Santé et de la Recherche Médicale Extracellular vesicles functionalized with an erv syncitin and uses thereof for cargo delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229426A (en) * 1978-02-22 1980-10-21 Duke University, Inc. Breast cyst fluid protein assay
US4440863A (en) * 1978-02-22 1984-04-03 Duke University Breast cyst fluid protein assay
IT1165552B (it) * 1979-01-30 1987-04-22 Otsuka Pharma Co Ltd Procedimento e corredo per determinare il livello di glicolegami associati a tumore
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB2114287B (en) * 1982-01-29 1985-10-30 Otsuka Pharma Co Ltd Process for determining tumor-associated glycolinkage
US4489166A (en) * 1982-05-27 1984-12-18 Research Corporation Monitoring of human endometrial function by radioimmunoassay of PEP
US4582787A (en) * 1982-12-30 1986-04-15 Frankel Jack W Method of testing a patient for a predisposition to lung cancer, certain other cancers, neurofibromatosis and certain other hereditary disorders
US4818709A (en) * 1983-01-21 1989-04-04 Primus Frederick J CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US4687733A (en) * 1984-01-30 1987-08-18 Ohio State University Early cancer detection method

Also Published As

Publication number Publication date
JPH0641172A (ja) 1994-02-15
EP0508776A1 (de) 1992-10-14
EP0508776B1 (de) 1995-09-13
CA2055695A1 (en) 1992-10-13
CA2055695C (en) 2004-04-13
AU8789191A (en) 1992-10-15
AU657102B2 (en) 1995-03-02
HK1000027A1 (en) 1997-10-09
JP3385572B2 (ja) 2003-03-10
DE69204718T2 (de) 1996-04-18
US5324822A (en) 1994-06-28

Similar Documents

Publication Publication Date Title
DE69203428D1 (de) Verbinder.
DE69005882D1 (de) Entfärbungsmittel.
DE69204718D1 (de) CA-195 ähnliches immunreaktives Antigen von menschlicher Amnionflüssigkeit.
DE69203171D1 (de) Verbinder.
DE69010010D1 (de) Eilabsenkventil.
FI910991A0 (fi) Vattenhaltig emulsion.
DE69203364D1 (de) Verbinder.
FI910639A0 (fi) Automatsaekringslaoda.
DE69201785D1 (de) Verbinder.
FI914231A0 (fi) Belagd isolerskiva.
FI914105A0 (fi) Sprinkleranlaeggning.
DE69202562D1 (de) Kieselsaürehaltiger offretit.
FI914153A0 (fi) Framdragbar saeng.
FI904766A0 (fi) Foerfarande foer detektering av protein.
FI914189A0 (fi) Biologisk gasrenare.
FI914188A0 (fi) Biologisk gasrenare.
FI911060A0 (fi) Last behandlingsanordning foer sjoecontainer.
ITTO910952A1 (it) Termostato.
FI913347A0 (fi) Ask.
FI914895A0 (fi) Under undertryck fungerande torkningsenhet foer en pappersmaskin.
ES1018067Y (es) Tarjeta-puzzle.
ES1018836Y (es) Cisterna-remolque.
FI910221A (fi) Veckbox.
FI910403A0 (fi) Gravitationsmaskin.
FI910581A0 (fi) Skensystem.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHIRON DIAGNOSTICS CORP. (N.D.GES.D. STAATES DELAW

8327 Change in the person/name/address of the patent owner

Owner name: BIO-RAD LABORATORIES, INC., HERCULES, CALIF., US

8339 Ceased/non-payment of the annual fee